12.85
+0.175(+1.38%)
Currency In USD
| Previous Close | 12.67 |
| Open | 12.59 |
| Day High | 12.9 |
| Day Low | 12.43 |
| 52-Week High | 18.07 |
| 52-Week Low | 11.94 |
| Volume | 242,934 |
| Average Volume | 1.11M |
| Market Cap | 1.29B |
| PE | -13.2 |
| EPS | -0.97 |
| Moving Average 50 Days | 14.02 |
| Moving Average 200 Days | 14.34 |
| Change | 0.13 |
If you invested $1000 in Day One Biopharmaceuticals, Inc. (DAWN) since IPO date, it would be worth $544.68 as of December 26, 2024 at a share price of $12.8. Whereas If you bought $1000 worth of Day One Biopharmaceuticals, Inc. (DAWN) shares 2 years ago, it would be worth $661.84 as of December 26, 2024 at a share price of $12.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 17, 2024 1:30 PM GMT
BRISBANE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
GlobeNewswire Inc.
Nov 20, 2024 9:30 PM GMT
Dr. Blackman’s departure planned for end of 2024 Company’s search for a new Head of R&D is ongoing BRISBANE, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 18, 2024 1:30 PM GMT
BRISBANE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with